High-Yield Rheumatology for USMLE Step 3: Arthritis, Lupus, and Vasculitis

I watched a resident lose 45 minutes on a CCS case because she ordered an ANA on a patient with monoarticular knee swelling. The answer was joint aspiration. It's always joint aspiration. Rheumatology on Step 3 isn't about memorizing antibody panels — it's about pattern recognition under time pressure, knowing which test actually changes your management, and not falling into the serology rabbit hole.

Here's what you actually need to lock down.

Systemic Lupus Erythematosus (SLE)

The Antibody Table Everyone Memorizes (But Few Actually Understand)

Yes, you need the table. But you need to understand why each antibody matters clinically, not just its sensitivity number.

Antibody	Sensitivity	Specificity	What It Actually Tells You
ANA	~95%	Low	Screening only. Positive in 15% of healthy women. A negative ANA essentially rules out SLE. A positive ANA rules out nothing by itself.
Anti-dsDNA	~70%	High	This is your activity marker. Rises before flares. Order this when you suspect nephritis.
Anti-Sm	~30%	Very high	Most specific antibody for SLE. Doesn't fluctuate with disease activity — it's a diagnostic stamp, not a monitoring tool.
Anti-Ro (SSA)	~40%	Moderate	Neonatal lupus, subacute cutaneous lupus, secondary Sjögren's. The antibody that crosses the placenta and causes congenital heart block.
Anti-La (SSB)	~15%	Moderate	Typically found alongside anti-Ro. Same neonatal lupus concern.
Antiphospholipid (aCL, lupus anticoag)	~35%	Moderate	Thrombosis and recurrent pregnancy loss. This is a separate syndrome that overlaps with SLE.

The single highest-yield lupus fact for Step 3: rising anti-dsDNA + falling C3/C4 = lupus flare, especially nephritis. If you see complement dropping on a lab panel, that kidney biopsy is coming next in the question stem. Don't wait for it — start thinking about treatment.

Lupus Nephritis — The Question They Always Ask

Class IV (diffuse proliferative) is the monster. Nephritic syndrome, active sediment, rising creatinine. The exam will hand you a renal biopsy description with "wire-loop" lesions and full-house immunofluorescence.

Treatment: mycophenolate mofetil + corticosteroids for induction. That's it. They're not testing you on cyclophosphamide versus mycophenolate nuance — they want you to pick the immunosuppressant and not just throw more prednisone at it.

Drug-Induced Lupus — The Freebie Question

This shows up reliably and it's almost always straightforward. The mnemonic HIPPP covers the major offenders: Hydralazine, Isoniazid, Procainamide, Phenytoin, Penicillamine. Minocycline and TNF inhibitors round out the modern list.

Three features distinguish it from idiopathic SLE:

• Anti-histone antibodies positive (ANA also positive)
• Complement levels are normal — this is the distinguishing lab finding
• Resolves when you stop the drug

Here's a contrarian take: drug-induced lupus is underdiagnosed in real practice but over-tested on boards. It's a pattern-match question. If the vignette mentions a drug from that list plus joint pain and serositis with normal complements, you're done. Don't overthink it.

Rheumatoid Arthritis

What the Vignette Looks Like

Symmetric polyarthritis. Small joints — MCPs, PIPs, wrists, MTPs. Morning stiffness lasting over an hour that improves with activity. The exam may throw in constitutional symptoms (fatigue, low-grade fevers, weight loss) to make you consider malignancy, but the symmetric small-joint pattern is unmistakable.

Critical distinction: RA spares the DIP joints. If you see DIP involvement, think osteoarthritis (Heberden's nodes) or psoriatic arthritis. This is a trick they use repeatedly.

Extra-articular features worth knowing:

• Rheumatoid nodules on extensor surfaces
• Interstitial lung disease / pulmonary fibrosis
• Felty syndrome: RA + splenomegaly + neutropenia (rare but classic board question)
• Scleritis and pericarditis

Treatment — The Decision Tree That Gets Tested

I've tutored hundreds of residents through Step 3 prep, and RA treatment is where people lose points not because they don't know the drugs, but because they don't know the sequence.

1. Methotrexate first. Always. Start early. Co-prescribe folic acid (reduces mouth sores, cytopenias, and liver toxicity). This is non-negotiable as the anchor DMARD.
2. Inadequate response at 3 months → add a biologic. Don't switch methotrexate — add to it.
   • TNF inhibitors (etanercept, adalimumab, infliximab) are the workhorses
   • Non-TNF options: abatacept (blocks T-cell costimulation), tocilizumab (IL-6 inhibitor), rituximab (anti-CD20)
   • JAK inhibitors (tofacitinib, baricitinib): oral alternatives, but carry VTE and cardiovascular risk warnings
3. Screen for latent TB before ANY biologic — IGRA or PPD. TNF inhibitors reactivate TB. This is a mandatory pre-treatment step that shows up as its own question.
4. Screen for hepatitis B before rituximab — can trigger fulminant hepatitis B reactivation.

Surprising insight: The exam doesn't test you on choosing between biologics. It tests whether you screen for TB and hepatitis B before starting them. The safety step is worth more points than the drug choice.

Crystal Arthropathies

Gout — Know the Crystals, Know the Timing

Joint aspiration is the gold standard. Period. Not serum uric acid (which can be normal during an acute flare — a fact that trips up a shocking number of test-takers).

Monosodium urate crystals: needle-shaped, negatively birefringent (yellow when parallel to the polarizer). The classic joint is the first MTP — podagra. But knees and ankles are fair game.

Risk factors: thiazide/loop diuretics, alcohol, purine-rich diet, CKD, cyclosporine, tumor lysis syndrome.

Acute flare management — pick one:

• NSAIDs (indomethacin, naproxen) — first-line if kidneys and GI are intact
• Colchicine (0.6 mg BID) — works well but avoid in significant CKD
• Corticosteroids — the fallback when everything else is contraindicated. Prednisone burst or intra-articular injection.

Chronic urate-lowering therapy — the timing rule: Start after the acute attack fully resolves. Starting allopurinol mid-flare can paradoxically worsen symptoms by shifting urate concentrations. Allopurinol is first-line (dose-reduce in CKD). Febuxostat for allopurinol-intolerant patients. Probenecid only if the patient is an underexcretor with normal renal function.

Pseudogout — The Other Crystal

Calcium pyrophosphate crystals: rhomboid-shaped, positively birefringent (blue when parallel). Large joints — knees and wrists, primarily.

The real value of pseudogout on Step 3 is the association list: hyperparathyroidism, hemochromatosis, hypomagnesemia. When you see pseudogout in a young patient, the question is really asking you to check calcium, iron studies, or magnesium.

Treatment mirrors acute gout (NSAIDs, colchicine, steroids). There's no urate-lowering equivalent — you can't prevent pseudogout the way you prevent gout. Manage the underlying metabolic condition instead.

Vasculitis — The Section That Scares Everyone

Vasculitis questions look complicated, but they follow rigid patterns. Learn the pattern, and these become some of the most predictable points on the exam.

Giant Cell Arteritis (GCA)

This is the emergency in rheumatology. A 72-year-old with new-onset headache, jaw claudication, scalp tenderness, and an ESR through the roof. The feared complication is irreversible blindness from anterior ischemic optic neuropathy.

The management rule that gets tested every single time: Start high-dose prednisone (40–60 mg/day) immediately on clinical suspicion. Do not wait for biopsy results. The temporal artery biopsy can happen later — steroids don't significantly alter the histology for at least 1–2 weeks.

If the patient already has visual symptoms: escalate to IV methylprednisolone 1g/day for 3 days before transitioning to oral.

One technical detail: skip lesions occur in ~30% of cases, so the biopsy sample should be at least 3 cm to reduce false negatives. The exam occasionally tests this.

Takayasu Arteritis

Young woman (under 40) with arm claudication, blood pressure discrepancies between arms, diminished pulses — "pulseless disease." Affects the aorta and its major branches. Treat with corticosteroids; add methotrexate or mycophenolate if refractory.

The diagnostic contrast with GCA is simple: Takayasu is young, GCA is old. Both are large-vessel, both are granulomatous, both respond to steroids. Age is the differentiator.

ANCA-Associated Vasculitides — The Table That Wins Points

Disease	ANCA Type	Target Organs	The Clue You Won't Miss
GPA (Granulomatosis with Polyangiitis)	c-ANCA (PR3)	Upper airway, lungs, kidneys	Saddle-nose deformity, sinus destruction, cavitary lung lesions
MPA (Microscopic Polyangiitis)	p-ANCA (MPO)	Lungs, kidneys	Pulmonary-renal syndrome with NO granulomas — the "clean" vasculitis
EGPA (Eosinophilic GPA / Churg-Strauss)	p-ANCA (MPO)	Lungs, heart, skin, nerves	Adult-onset asthma + peripheral eosinophilia. If the vignette says "asthma" plus multi-organ disease, this is it.

Induction treatment: Rituximab or cyclophosphamide + high-dose steroids. Rituximab has become preferred for GPA and MPA — it's equally effective with a better side-effect profile than cyclophosphamide. Maintenance: Azathioprine or methotrexate (or continued rituximab).

A pearl I wish someone had told me earlier: The exam differentiates GPA from MPA based on granulomas and upper airway involvement, not ANCA type. Both can be p-ANCA positive in atypical cases. If there's sinus destruction or saddle-nose deformity, it's GPA regardless of the ANCA pattern.

FAQ

How do I distinguish RA from SLE on a Step 3 vignette?

Both cause polyarthritis, but the patterns diverge. RA is symmetric small-joint arthritis with erosions and deformity — it destroys joints. SLE arthritis is typically non-erosive (Jaccoud's arthropathy shows deformity without bony erosion). SLE also comes with multi-system features: malar rash, serositis, cytopenias, renal disease. If the question mentions skin findings plus joint pain plus abnormal urinalysis, think lupus. If it's purely joint destruction with morning stiffness, think RA.

When should I start urate-lowering therapy in gout?

Not during an acute flare. Wait until the attack has fully resolved, then initiate allopurinol with a prophylactic low-dose colchicine or NSAID cover for the first 3–6 months (to prevent the mobilization flares that happen when serum urate levels shift). The target serum urate is below 6 mg/dL. Patients with tophi, frequent attacks (≥2/year), or CKD should be on long-term urate-lowering therapy.

Can GCA biopsy be negative?

Yes — and it doesn't rule out the diagnosis. Skip lesions mean about 30% of biopsies can miss the affected segment. If your clinical suspicion is high (classic symptoms, elevated ESR/CRP, response to steroids), you treat regardless of biopsy results. Some institutions now use temporal artery ultrasound (halo sign) as an adjunct. The exam may test whether you continue steroids after a negative biopsy in a patient who clinically improved.

What's the most common cause of death in SLE?

Early in the disease course, it's infections (from immunosuppression). Late in the disease course, it's cardiovascular disease — accelerated atherosclerosis. This is a board favorite because the intuitive answer is "lupus nephritis," but renal disease is a major cause of morbidity, not the leading cause of death in the modern era.

How do I remember which crystal is which?

Negative birefringence = gout = needle-shaped = yellow parallel. Think of it this way: gout is negative because it makes you miserable. Or use the classic: "gout is yellow and angry." Pseudogout is positively birefringent, rhomboid, blue parallel. Honestly, if you just remember "gout = negative, needle, yellow" the rest falls into place by elimination.

Put It to the Test

Rheumatology rewards pattern recognition — and the only way to build that is through practice. Step3Sim has free USMLE Step 3 practice questions covering rheumatology and every other discipline. Work through the cases until the patterns become reflexive.